Hu Ting, Li Xiong, Zhang Qinghua, Huang Kecheng, Jia Yao, Yang Ru, Tang Fangxu, Tian Qiang, Ma Ding, Li Shuang
Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China.
Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China; Department of Gynecology & Obstetrics, the Central Hospital of Wuhan, Wuhan, P.R. China.
PLoS One. 2015 Apr 10;10(4):e0123539. doi: 10.1371/journal.pone.0123539. eCollection 2015.
The effect of neoadjuvant chemotherapy (NACT) on topographical distribution patterns of lymph node metastasis in cervical cancer was unknown.
Patients with FIGO stage IB1-IIB who underwent radical surgery with or without NACT were enrolled (3527 patients). A matched-case comparison design was used to compare the effects of NACT on lymph node metastasis.
We analyzed groups of 167 and 140 patients who were diagnosed with lymph node metastasis in the matched primary surgery group and NACT group, respectively, and no significant difference was observed (p = 0.081). The incidence of lymph node metastasis was significantly decreased in the NACT-responsive group compared to the non-responsive group (18.4% vs. 38.6%, P<0.001). The metastatic rates for every lymph node group also declined in the NACT-responsive group except for the deep inguinal and the para-aortic lymph node groups. Clinical response, deep stromal, parametrial and lymph vascular invasions were independent risk factors for lymph node metastasis in the NACT group. Furthermore, deep stromal invasion and lymph vascular invasion, but not the response to NACT, were independently associated with upper LNM. The number of lymph nodes involved, response to NACT, tumor histology and a positive vaginal margin were independent prognostic factors affecting DFS or OS rates in node-positive patients treated with NACT plus radical surgery.
The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.
新辅助化疗(NACT)对宫颈癌淋巴结转移的拓扑分布模式的影响尚不清楚。
纳入接受了根治性手术(无论是否接受NACT)的FIGO IB1-IIB期患者(3527例)。采用配对病例对照设计比较NACT对淋巴结转移的影响。
我们分别分析了配对的初次手术组和NACT组中被诊断为淋巴结转移的167例和140例患者,未观察到显著差异(p = 0.081)。与无反应组相比,NACT反应组的淋巴结转移发生率显著降低(18.4%对38.6%,P<0.001)。除腹股沟深部和主动脉旁淋巴结组外,NACT反应组中每个淋巴结组的转移率也有所下降。临床反应、深部间质、宫旁和淋巴管浸润是NACT组淋巴结转移的独立危险因素。此外,深部间质浸润和淋巴管浸润而非对NACT的反应与上淋巴结转移独立相关。受累淋巴结数量、对NACT的反应、肿瘤组织学和阴道切缘阳性是影响接受NACT加根治性手术的淋巴结阳性患者DFS或OS率的独立预后因素。
NACT不会改变淋巴结转移的频率和拓扑分布,临床无反应者的受累淋巴结更多。无论对NACT的反应如何,接受NACT加手术治疗的患者均应进行系统性广泛淋巴结清扫术。